ICU predictive factors of fibrotic changes following COVID-19 related ARDS: a RECOVIDS substudy.

ABSTRACT:

Background

Pulmonary fibrotic changes (FC) following COVID-19-related ARDS represent a significant concern due to the potential respiratory complications. The identification of early predictive factors for FC and the development of predictive tools are needed to optimize patient management and outcomes.

Methods

This observational prospective multicentre study is a substudy of the RECOVIDS study and included 32 centres in France and Belgium. COVID-19 ARDS survivors were included if they met the Berlin ARDS criteria or if they received high flow oxygen therapy (flow ≥ 50 L/min and FiO₂ ≥ 50%). Exclusion criteria were non-attendance at follow-up 6 ± 1 months after ICU discharge, lack of baseline or follow-up chest CT, and history of interstitial lung disease. The pri

SUBMITTER: Demeyere M 

PROVIDER: S-EPMC12583252 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature